Status:
COMPLETED
Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.
Lead Sponsor:
Changhai Hospital
Conditions:
Pancreatitis, Chronic
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study aims to determine the optimal timing of endoscopic intervention after extracorporeal shock wave lithotripsy(ESWL) of chronic pancreatitis with pancreatic stones.
Detailed Description
Chronic pancreatitis（CP）is a chronic progressive fibro-inflammatory disease of the pancreas induced by a wide range of factors including genetic and environmental elements, with recurrent abdominal pa...
Eligibility Criteria
Inclusion
- symptomatic adult patients diagnosed with chronic pancreatitis and main pancreatic duct positive stones（\>5mm in diameter）
- no ERCP and ESWL history before the admission
- provides informed consent
Exclusion
- suspected to have malignant tumors;
- history of pancreatic surgery or gastrojejunostomy (Billroth II);
- with end-stage disease;
- with contraindications to ESWL or ERCP, such as pregnancy, abdominal aortic aneurysm, etc.
- acute pancreatitis within 3 days
- pancreatic ascites
Key Trial Info
Start Date :
March 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05270434
Start Date
March 12 2025
End Date
October 20 2025
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433